Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 4Phase 1/2 2Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Breast Neoplasms 1059Neoplasms 885Prostatic Neoplasms 510Lung Neoplasms 426Colorectal Neoplasms 358Motor Activity 226Uterine Cervical Neoplasms 194Head and Neck Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 174Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Endometrial Neoplasms 87Glioblastoma 86Disease 85Lymphoma 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelomonocytic, Juvenile × 1 year × Clear all
NCT03810196 2026-02-20

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Children's Hospital of Philadelphia

Phase NA Recruiting
50 enrolled
LymphoidMyeloidOther hematologic neoplasm

Burkitt Lymphoma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡